News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
713,079 Results
Type
Article (40877)
Company Profile (298)
Press Release (671903)
Multimedia
Podcasts (83)
Webinars (13)
Section
Business (207173)
Career Advice (2075)
Deals (35902)
Drug Delivery (100)
Drug Development (82452)
Employer Resources (176)
FDA (16302)
Job Trends (15193)
News (350333)
Policy (32916)
Tag
Academia (2576)
Accelerated approval (7)
Adcomms (22)
Allergies (93)
Alliances (50344)
ALS (103)
Alzheimer's disease (1438)
Antibody-drug conjugate (ADC) (159)
Approvals (16295)
Artificial intelligence (302)
Autoimmune disease (27)
Automation (18)
Bankruptcy (364)
Best Places to Work (11757)
BIOSECURE Act (21)
Biosimilars (113)
Biotechnology (212)
Bladder cancer (89)
Brain cancer (34)
Breast cancer (354)
Cancer (2743)
Cardiovascular disease (207)
Career advice (1732)
Career pathing (33)
CAR-T (177)
CDC (30)
Cell therapy (483)
Cervical cancer (22)
Clinical research (67650)
Collaboration (976)
Company closure (3)
Compensation (641)
Complete response letters (21)
COVID-19 (2639)
CRISPR (53)
C-suite (299)
Cystic fibrosis (110)
Data (2825)
Decentralized trials (2)
Denatured (28)
Depression (56)
Diabetes (310)
Diagnostics (6432)
Digital health (22)
Diversity (9)
Diversity, equity & inclusion (46)
Drug discovery (131)
Drug pricing (123)
Drug shortages (27)
Duchenne muscular dystrophy (119)
Earnings (88411)
Editorial (46)
Employer branding (23)
Employer resources (151)
Events (116037)
Executive appointments (846)
FDA (17852)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (886)
Gene editing (126)
Generative AI (22)
Gene therapy (364)
GLP-1 (784)
Government (4524)
Grass and pollen (5)
Guidances (180)
Healthcare (18922)
Huntington's disease (29)
IgA nephropathy (34)
Immunology and inflammation (136)
Immuno-oncology (7)
Indications (38)
Infectious disease (2793)
Inflammatory bowel disease (149)
Inflation Reduction Act (10)
Influenza (56)
Intellectual property (115)
Interviews (329)
IPO (16814)
IRA (44)
Job creations (3842)
Job search strategy (1469)
Kidney cancer (13)
Labor market (50)
Layoffs (502)
Leadership (23)
Legal (7972)
Liver cancer (78)
Lung cancer (384)
Lymphoma (195)
Machine learning (9)
Management (58)
Manufacturing (365)
MASH (88)
Medical device (13444)
Medtech (13449)
Mergers & acquisitions (19768)
Metabolic disorders (795)
Multiple sclerosis (96)
NASH (16)
Neurodegenerative disease (112)
Neuropsychiatric disorders (33)
Neuroscience (2090)
NextGen: Class of 2025 (6575)
Non-profit (4505)
Now hiring (47)
Obesity (411)
Opinion (233)
Ovarian cancer (95)
Pain (102)
Pancreatic cancer (110)
Parkinson's disease (180)
Partnered (22)
Patents (284)
Patient recruitment (140)
Peanut (49)
People (58456)
Pharmaceutical (76)
Pharmacy benefit managers (21)
Phase I (21127)
Phase II (29862)
Phase III (22101)
Pipeline (1562)
Policy (196)
Postmarket research (2573)
Preclinical (8986)
Press Release (64)
Prostate cancer (134)
Psychedelics (32)
Radiopharmaceuticals (262)
Rare diseases (438)
Real estate (6038)
Recruiting (67)
Regulatory (22757)
Reports (50)
Research institute (2346)
Resumes & cover letters (355)
Rett syndrome (9)
RNA editing (8)
RSV (45)
Schizophrenia (82)
Series A (149)
Series B (99)
Service/supplier (11)
Sickle cell disease (57)
Special edition (20)
Spinal muscular atrophy (147)
Sponsored (33)
Startups (3667)
State (2)
Stomach cancer (13)
Supply chain (75)
Tariffs (59)
The Weekly (53)
Vaccines (764)
Venture capital (51)
Weight loss (254)
Women's health (46)
Worklife (20)
Date
Today (54)
Last 7 days (477)
Last 30 days (2465)
Last 365 days (31784)
2025 (15514)
2024 (35730)
2023 (40661)
2022 (51785)
2021 (56339)
2020 (54535)
2019 (46980)
2018 (35385)
2017 (32635)
2016 (32060)
2015 (38110)
2014 (32005)
2013 (26893)
2012 (29013)
2011 (29668)
2010 (27706)
Location
Africa (742)
Alabama (64)
Alaska (7)
Arizona (244)
Arkansas (14)
Asia (39429)
Australia (6360)
California (7199)
Canada (2268)
China (661)
Colorado (307)
Connecticut (313)
Delaware (183)
Europe (85189)
Florida (1086)
Georgia (242)
Idaho (58)
Illinois (617)
India (26)
Indiana (352)
Iowa (16)
Japan (211)
Kansas (108)
Kentucky (28)
Louisiana (13)
Maine (64)
Maryland (1010)
Massachusetts (5386)
Michigan (241)
Minnesota (438)
Mississippi (3)
Missouri (85)
Montana (28)
Nebraska (25)
Nevada (77)
New Hampshire (66)
New Jersey (2002)
New Mexico (29)
New York (2032)
North Carolina (1108)
North Dakota (8)
Northern California (3163)
Ohio (228)
Oklahoma (15)
Oregon (35)
Pennsylvania (1563)
Puerto Rico (18)
Rhode Island (36)
South America (1122)
South Carolina (33)
South Dakota (1)
Southern California (2685)
Tennessee (120)
Texas (1074)
United States (26839)
Utah (214)
Virginia (178)
Washington D.C. (73)
Washington State (617)
West Virginia (4)
Wisconsin (63)
713,079 Results for "enteris biopharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Career Advice
The Top 12 Companies Hiring in Biopharma Now
Looking for a biopharma job? Check out the
BioSpace
list of 12 top companies hiring life sciences professionals like you.
June 5, 2025
·
1 min read
·
Angela Gabriel
Mergers & acquisitions
Biopharma Deal Premiums Paint Picture of Cutthroat Negotiations
Sanofi paid a more than 300% premium on its acquisition of Vigil Neuroscience, suggesting a fierce battle to seal the deal. Across biopharma, companies are sometimes willing to put it all on the line for the right buyout. Novartis’ recent acquisition of Regulus for $800 million upfront provides a case study.
June 18, 2025
·
4 min read
·
Annalee Armstrong
Job Trends
Exit Strategy: Biopharma Pros Look Outside Industry—and US
A
BioSpace
survey found that 56% of employed and 81% of unemployed respondents are considering jobs outside biopharma. Some are also seriously thinking about leaving the U.S. to find employment in the field.
May 22, 2025
·
6 min read
·
Angela Gabriel
Layoffs
Q1 Biopharma Layoffs Hit California, Massachusetts Hard
During the first quarter, 22 rounds of biopharma layoffs in California affected about 995 employees total, while 17 rounds in Massachusetts impacted around 410 people, based on
BioSpace
estimates. Meanwhile, competition for jobs in those states increased year over year, according to
BioSpace
data.
April 17, 2025
·
5 min read
·
Angela Gabriel
Job Trends
Sounding Off: Political Climate, Job Market Have Some Eyeing Biopharma Work Abroad
Nearly a third of employed and almost half of unemployed
BioSpace
survey respondents are seriously considering leaving the U.S. to find biotech and pharma jobs. Concerns about how the political climate is affecting biopharma are a key driver for many.
May 29, 2025
·
5 min read
·
Angela Gabriel
Press Releases
Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference May 21
May 8, 2025
·
2 min read
Job Trends
Biopharma Employees’ Confidence in Employers Dips Month-Over-Month in February
Biopharma employees reporting a positive business outlook for their companies dropped month over month but increased year over year in February, according to the Glassdoor Employee Confidence Index. Glassdoor’s findings align with recent
BioSpace
data.
March 27, 2025
·
2 min read
·
Angela Gabriel
Press Releases
Avirmax Biopharma Inc. to Present at the 2025 ARVO Annual Meeting in Salt Lake City
April 23, 2025
·
2 min read
Policy
Trump’s Whiplash Tariffs and HHS Layoffs Set Biopharma Industry Ablaze
As the biopharma industry grapples with the uncertain macro environment brought on by the new administration, CEOs, regulators and many others speak out.
April 11, 2025
·
3 min read
·
BioSpace Editorial Staff
Press Releases
Aspire Biopharma Holdings, Inc., to Present at the Emerging Growth Conference on Thursday, April 17
April 14, 2025
·
3 min read
1 of 71,308
Next
